XBB.1.5更新的新冠疫苗对丹麦住院治疗的短期有效性：一项全国队列研究 - Suppr

Short-term effectiveness of the XBB.1.5 updated COVID-19 vaccine against hospitalisation in Denmark: a national cohort study.

作者信息

Hansen Christian Holm, Moustsen-Helms Ida Rask, Rasmussen Morten, Søborg Bolette, Ullum Henrik, Valentiner-Branth Palle

机构信息

Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Artillerivej 5, 2300 Kbh S, Denmark; MRC International Statistics and Epidemiology Group, London School of Hygiene and Tropical Medicine, London, UK.

Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Artillerivej 5, 2300 Kbh S, Denmark.

出版信息

Lancet Infect Dis. 2024 Feb;24(2):e73-e74. doi: 10.1016/S1473-3099(23)00746-6. Epub 2024 Jan 5.

DOI:10.1016/S1473-3099(23)00746-6

PMID:38190834

Abstract

摘要

相似文献

Short-term effectiveness of the XBB.1.5 updated COVID-19 vaccine against hospitalisation in Denmark: a national cohort study.

Lancet Infect Dis. 2024 Feb;24(2):e73-e74. doi: 10.1016/S1473-3099(23)00746-6. Epub 2024 Jan 5.

Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023.

Euro Surveill. 2024 Jan;29(3). doi: 10.2807/1560-7917.ES.2024.29.3.2300708.

Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023.

MMWR Morb Mortal Wkly Rep. 2023 Feb 3;72(5):119-124. doi: 10.15585/mmwr.mm7205e1.

Effectiveness of BNT162b2 BA.4/5 bivalent mRNA vaccine against a range of COVID-19 outcomes in a large health system in the USA: a test-negative case-control study.

Lancet Respir Med. 2023 Dec;11(12):1089-1100. doi: 10.1016/S2213-2600(23)00306-5. Epub 2023 Oct 25.

Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July-November 2021.

BMC Med. 2022 Sep 2;20(1):278. doi: 10.1186/s12916-022-02480-4.

COVID-19 mRNA vaccine effectiveness (second and first booster dose) against hospitalisation and death during Omicron BA.5 circulation: cohort study based on electronic health records, Portugal, May to July 2022.

Euro Surveill. 2022 Sep;27(37). doi: 10.2807/1560-7917.ES.2022.27.37.2200697.

Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.

PLoS Med. 2022 Sep 1;19(9):e1003992. doi: 10.1371/journal.pmed.1003992. eCollection 2022 Sep.

Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control study.

Lancet Infect Dis. 2023 Nov;23(11):1235-1243. doi: 10.1016/S1473-3099(23)00365-1. Epub 2023 Jul 12.

Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2023.

MMWR Morb Mortal Wkly Rep. 2023 Oct 20;72(42):1140-1146. doi: 10.15585/mmwr.mm7242e1.

Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden.

Lancet. 2022 Feb 26;399(10327):814-823. doi: 10.1016/S0140-6736(22)00089-7. Epub 2022 Feb 4.

引用本文的文献

Safety and Immunogenicity of aerosolized adenovirus-vectored COVID-19 vaccine and intramuscular mRNA vaccine bivalent boosters: a randomized open-label clinical trial.

Nat Commun. 2025 Aug 7;16(1):7281. doi: 10.1038/s41467-025-62698-7.

Vaccine Effectiveness Among 5- to 17-year-old Individuals with Prior SARS-CoV-2 Infection: An EHR-Based Target Trial Emulation Study from the RECOVER Project.

Res Sq. 2025 Jul 3:rs.3.rs-6945998. doi: 10.21203/rs.3.rs-6945998/v1.

Immune imprinting and vaccine interval determine antibody responses to monovalent XBB.1.5 COVID-19 vaccination.

Commun Med (Lond). 2025 May 17;5(1):182. doi: 10.1038/s43856-025-00898-4.

Estimating population immunity to SARS-CoV-2 by random sampling from primary and secondary healthcare in Scotland, May 2024.

EBioMedicine. 2025 Jun;116:105760. doi: 10.1016/j.ebiom.2025.105760. Epub 2025 May 16.

SARS-CoV-2 Fusion Peptide-Directed Antibodies Elicited by Natural Infection Mediate Broad Sarbecovirus Neutralization.

medRxiv. 2025 Mar 5:2025.03.01.25323010. doi: 10.1101/2025.03.01.25323010.

XBB.1.5 mRNA COVID-19 vaccine protection against inpatient or emergency department visits among adults infected with SARS-CoV-2 JN.1 and XBB-lineage variants.

Front Immunol. 2025 Feb 17;16:1470609. doi: 10.3389/fimmu.2025.1470609. eCollection 2025.

Vaccine Effectiveness Among 5- to 17-year-old Individuals with Prior SARS-CoV-2 Infection: An EHR-Based Target Trial Emulation Study from the RECOVER Project.

medRxiv. 2025 Feb 8:2025.02.07.25321814. doi: 10.1101/2025.02.07.25321814.

Comparative effectiveness of monovalent XBB.1.5 containing covid-19 mRNA vaccines in Denmark, Finland, and Sweden: target trial emulation based on registry data.

BMJ Med. 2024 Nov 17;3(1):e001074. doi: 10.1136/bmjmed-2024-001074. eCollection 2024.

Neutralizing antibody responses to three XBB protein vaccines in older adults.

Signal Transduct Target Ther. 2025 Feb 3;10(1):48. doi: 10.1038/s41392-025-02132-y.

COVID-19 vaccine effectiveness against SARS-CoV-2-confirmed hospitalisation in the eastern part of the WHO European Region (2022-2023): a test-negative case-control study from the EuroSAVE network.

Lancet Reg Health Eur. 2024 Oct 22;47:101095. doi: 10.1016/j.lanepe.2024.101095. eCollection 2024 Dec.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Short-term effectiveness of the XBB.1.5 updated COVID-19 vaccine against hospitalisation in Denmark: a national cohort study.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献